跳至主要内容
临床试验/NCT04094714
NCT04094714Unknown不适用

CHACO Study: Control of Arterial Hypertension in Colombian Patients

Scandinavia Pharma1 个研究点 分布在 1 个国家目标入组 1,100 人开始时间: 2019年6月27日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1,100
试验地点
1
主要终点
Patients with adequate control of the Blood Pressure (BP)

研究概览

简要总结

Epidemiological study (cross-sectional study) in order to determine the patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

详细描述

OBJECTIVE

To determine the proportion of patients who present an adequate control of the Blood Pressure (BP), in a population of Colombian patients diagnosed with Arterial Hypertension (AH) and who are under pharmacological treatment.

MATERIALS AND METHODS

Epidemiological study (cross-sectional study), multicentre type, in patients older than 18 years with prior diagnosis of AH in Colombia. The blood pressure control will be evaluated as the main variable (only one single blood pressure check in the doctor's office). Other secondary variables to evaluate are: demographical analysis, type (s) of antihypertensive treatment (s) used in patients, level of BP control, adverse events associated with antihypertensive treatment, comorbidities and risk factors, adherence, perception about the possible benefits of the use of combined therapy in "mono-tablet" versus "multi-tablet". The analysis will be carried out from two perspectives: A first descriptive approach and a second analytical approach, with a level of significance of 5%.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Prior diagnosis of Arterial Hypertension (AH) ≥ 3 months before
  • Patients who are under pharmacological treatment of AH ≥ 3 months before

排除标准

  • The patient has rejected the participation in the study.
  • Patients who, in the judgment of the Investigator, do not understand or are not willing to adequately answer the questions.
  • Mental or psychiatric illness that, in the judgment of the investigator, does not allow adequate information to be obtained.

结局指标

主要结局

Patients with adequate control of the Blood Pressure (BP)

时间窗: It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years.

Proportion of patients who present an adequate control of the Blood Pressure (BP)

次要结局

  • Adverse Events related with the treatment(It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years.)
  • Personal history of diseases(It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years.)
  • Treatment analysis(It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years.)
  • Demographic analysis(It will be evaluated in each patient (only once, at the time of the interview) throughout the study which is estimated to last 3 years.)

研究者

发起方
Scandinavia Pharma
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验